Monoclonal Gammopathy of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Monoclonal Gammopathy of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma [Phase 1]
This Phase 1 trial evaluated the cardiac effects of siltuximab in patients with Monoclonal Gammopathy of Undetermined Significance and Multi…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Imaging in MGUS, SMM and MM [Phase 2]
Completed Phase 2 clinical trial evaluating imaging in monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and …
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance [Phase 2]
Phase 2 trial of rituximab in patients with peripheral neuropathy caused by monoclonal gammopathy of undetermined significance was terminate…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy [NA]
Clinical trial update reporting completion of a prognostic study of angiogenesis and coagulability markers in patients with monoclonal gammo…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) [Phase 2]
A Phase 2 trial investigating prevention of disease progression in early-stage indolent B-cell malignancies (MGUS, smoldering multiple myelo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.